[Epoetin-induced pure red-cell aplasia].
作者信息
Torreman M
出版信息
Ned Tijdschr Geneeskd. 2005 Feb 26;149(9):497-8; author reply 498.
PMID:15771350
Abstract
摘要
相似文献
1
[Epoetin-induced pure red-cell aplasia].
Ned Tijdschr Geneeskd. 2005 Feb 26;149(9):497-8; author reply 498.
2
[Epoetin-induced pure red-cell aplasia].
Ned Tijdschr Geneeskd. 2004 Dec 18;148(51):2550-3.
3
Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
Am J Gastroenterol. 2005 Jun;100(6):1415-9. doi: 10.1111/j.1572-0241.2005.41910.x.
4
The (re)challenging question of erythropoiesis-stimulating agents inducing pure red cell aplasia.
Nephrol Dial Transplant. 2008 Oct;23(10):3053-5. doi: 10.1093/ndt/gfn326. Epub 2008 Jun 16.
5
Pure red cell aplasia and anti-erythropoietin antibodies in patients treated with epoetin.
Nephrol Dial Transplant. 2003 Nov;18 Suppl 8:viii37-41. doi: 10.1093/ndt/gfg1091.
6
Two cases of pure red-cell aplasia due to anti-erythropoietin antibodies.
J Nephrol. 2005 Jan-Feb;18(1):102-5.
7
Recovery from anti-recombinant-human-erythropoietin associated pure red cell aplasia in end-stage renal disease patients after renal transplantation.
Nephrol Dial Transplant. 2005 Mar;20(3):626-30. doi: 10.1093/ndt/gfh666.
8
Pure red cell aplasia induced by erythropoiesis-stimulating agents.
Clin J Am Soc Nephrol. 2008 Jan;3(1):193-9. doi: 10.2215/CJN.02440607.
9
Relationship between biopharmaceutical immunogenicity of epoetin alfa and pure red cell aplasia.
Curr Med Res Opin. 2003;19(5):433-4. doi: 10.1185/030079903125002072.
10
Clinical characteristics of erythropoietin-associated pure red cell aplasia.
Best Pract Res Clin Haematol. 2005;18(3):467-72. doi: 10.1016/j.beha.2005.01.015.
Zotero 插件